Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052449 · ClinicalTrials.gov registry record · NA
Assessing Social Determinants of Health to Increase Cancer Screening
A NA study, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT06052449: Completed NA study, sponsored by Hackensack Meridian Health.
NCT06052449 is a NA study that has completed, run by Hackensack Meridian Health. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06052449, a NA study, has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
A multilevel lung screening intervention that pairs Social Determinants of Health (SDoH) screening and referral with a tailored health communication and decision support tool for lung screening has the potential to significantly impact lung screening uptake among at-risk individuals in the community, particularly among those who face barriers related to SDoH. In addition, findings will advance the understanding of effective strategies for improving lung screening and prevention efforts in non-traditional settings, with the ultimate goal of reducing the burden of lung cancer. As ways to support the realization of the public health benefit of lung cancer screening are considered, multiple strategies and venues to reach, and intervene, with screening-eligible is key. The goal of this study is to compare the effectiveness of a community-based lung screening educational tool paired with a social determinants of health (SDoH) screening assessment and referral process compared to a community-based lung cancer screening (LCS) educational tool alone as part of community outreach activities to improve (a) LCS rates (primary outcome); (b) intention to screen; and (c) individual-level potential drivers of LCS (health literacy, mistrust, stigma, fatalism, knowledge, health beliefs). It is hypothesized that providing SDoH screening and referral will result in higher levels of LCS, forward movement of intention to screen, and improved individual-level drivers of LCS.
Primary Outcome
Number of participants in the two groups that get screened (have a computed tomography (CT or CAT) scan)
Interventions
- BEHAVIORAL Social determinants of health screening assessment and referral process
- BEHAVIORAL Current practice - Community-based lunch cancer screening (LungTalk)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2023-09-30 |
| Est. Completion | 2025-08-19 |
| Phase | NA |
What the finished NCT06052449 record still lists
NCT06052449 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Social determinants of health screening assessment and referral process is the first listed.
NCT06052449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06052449 about?
NCT06052449 is a clinical study titled "Assessing Social Determinants of Health to Increase Cancer Screening". A multilevel lung screening intervention that pairs Social Determinants of Health (SDoH) screening and referral with a tailored health communication and decision support tool for lung screening has the potential to significantly impact lung screening uptake among at-risk individuals in the community...
What is the current status of trial NCT06052449?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2023-09-30. Estimated completion is 2025-08-19.
What interventions are being tested in trial NCT06052449?
The interventions under investigation include: Social determinants of health screening assessment and referral process (BEHAVIORAL), Current practice - Community-based lunch cancer screening (LungTalk) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06052449?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06052449's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI